<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             J Biol Chem. 2008 January 4; 283(1): 350&#226;&#8364;&#8220;357. doi:10.1074/jbc.M705028200. <br />  <br />  <br />  <br />                            Pharmacogenetic Analysis Lithium-induced Delayed Aging                            Caenorhabditis elegans*,S <br />  <br />                            Gawain McColl&#226;&#8364;&#161;,1, David W. Killilea&#194;&#167;, Alan E. Hubbard&#194;&#182;, Maithili C. Vantipalli&#226;&#8364;&#161;, Simon <br />                            Melov&#226;&#8364;&#161;,2, Gordon J. Lithgow&#226;&#8364;&#161;,3 <br />                            &#226;&#8364;&#161;Buck Institute Age Research, Novato, California 94945 <br />  <br />                            &#194;&#167;Nutrition Metabolism Center, Children&#226;&#8364;&#8482;s Hospital Oakland Research Institute, Oakland, <br />                            California 94609 <br />                            &#194;&#182;School    Public Health, University California, Berkeley California 94720 <br />  <br />                            Abstract <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 Lithium (Li+) used treat mood affect disorders, including bipolar, decades. drug <br />                                 neuroprotective identified molecular targets.  narrow therapeutic <br />                                 range underlying mechanisms therapeutic action understood.                                 pharmacogenetic study Li+ nematode Caenorhabditis elegans. Exposure                                 Li+ clinically relevant concentrations adulthood increases survival normal aging <br />                                  46% median increase). Longevity extended novel mechanism altered expression <br />                                 genes encoding nucleosome-associated functions. Li+ treatment results reduced expression                                 worm ortholog LSD-1 (T08D10.2), histone demethylase; knockdown RNA interference <br />                                 T08D10.2 sufficient extend longevity (~25% median increase), suggesting Li+ regulates <br />                                 survival modulating histone methylation chromatin structure. <br />  <br />                                              Genetic studies lifespan determination revealed large number potential targets                                              <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span>chemical</span> compounds slow aging. aging major risk factor human disease, <br />                                              compounds prove useful postponing age-related diseases. number compounds <br />                                              shown extend lifespan simple animals nematode Caenorhabditis <br />                                              elegans. range compounds known antioxidant activities superoxide <br />                                              dismutase/catalase mimetics EUK-8 EUK-134 (1&#226;&#8364;&#8220;3), compounds appear <br />                                              act modulation neural activity (4) anticonvulsants ethosuximide, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              trimethadione, 3,3-diethyl-2-pyrrolidinone. natural products associated                                              lifespan extension, including polyphenol resveratrol, increases lifespan yeast (5), <br />                                              C. elegans, fly Drosophila melanogaster (6). <br />  <br />                             microarray data available Gene Expression Omnibus accession number GSE8058. Gene expression studies                            facilitated Nathan Shock award (P30AG025708). nematode strains obtained Caenorhabditis Genetics Center, <br />                            funded National Institutes Health (NIH) National Center Research Resources. <br />                            SThe line version article (available http://www.jbc.org) contains supplemental &#226;&#8364;&#339;Experimental Procedures,&#226;&#8364;? Figs. S1 S2, <br />                            Tables S1&#226;&#8364;&#8220;S5. <br />                            1Supported American Federation Aging Research. <br />                            2Supported Ellison Medical Research Foundation NIH Grants AG24385 AG18679. <br />                            3Supported NIH Grants AG21069, AG22868, NS050789-01, Ellison Medical Resarch Foundation, Glenn Foundation                            Medical Research, American Federation Aging Research, Larry L. Hillblom Foundation, Herbert Simon Family <br />                            Medical Foundation. <br />                            &#194;&#169; 2008 American Society Biochemistry Molecular Biology,  <br />                            correspondence addressed (present address): Mental Health Research Institute Victoria, 155 Oak St, Parkville, <br />                            Victoria 3052, Australia. Tel.: 61-3-9389-2971; Fax: 61-3-9380-6182; gmccoll@mhri.edu.au. <br />                             McColl et al.                                                                                                                  Page 2 <br />  <br />  <br />                                                 alkali metal <span id='am-5' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-6' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="ion" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span>ion</span> Li+ affects diverse biological processes, range developmental <br />                                                 effects simple metazoans metabolic alterations mammals (7). Despite clinical use <br />                                                 (8,9), mechanism action brain remains unclear (10).  NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 molecular targets identified, including inositol monophosphatase                                                 phosphomonoesterases (11), sodium coupled citrate transporter (12), glycogen synthase <br />                                                 kinase-3&#206;&#178; (GSK-3&#206;&#178;)4 (7). <br />  <br />                                                 Li+ neuroprotective effects; rats, Li+ treatment results elevation bcl-2 levels                                                 brain regions (13,14). C. elegans ortholog neuroprotective protein (CED-9) <br />                                                 (15) functions prevent cell death development (16,17). models neurological <br />                                                 disease, Li+ shown reverse axon transport deficiencies transgenic Drosophila <br />                                                 (18) reduce insoluble tau (19), abrogate axonal degeneration (20), decrease &#206;&#178;-amyloid <br />                                                 production mice (21). studies cultured cerebellar granule cells rats, Li+ protected <br />                                                 apoptosis induced anticonvulsants (22). Li+ protects cells models Huntington <br />                                                 disease (HD) (23) toxicity caused aggregate-prone proteins containing                                                 polyglutamine polyalanine expansions Drosophila (24). Li+ improve <br />                                                 neurological function pathology Spinocerebellar Ataxia Type 1 mouse model (25). <br />                                                 Recently, Li+ shown protect C. elegans toxic effects expression fragment <br />                                                 huntingtin protein containing expanded polyglutamine tract associated human HD <br />                                                 (26). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 understand mechanisms Li+ action taken pharmacogenetic approach                                                 C. elegans. does allow mediators Li+ action identified,                                                 allows assessment general effects drug organism. <br />  <br />                               EXPERIMENTAL PROCEDURES <br />                               Strains <br />                                                 Bristol N2: wild-type, CB4876: clk-1(e2519), CF1038: daf-16(mu86), DA465: eat-2(ad465), <br />                                                 DR1572: daf-2(e1368), MT3970: mab-5(mv114) ced-9(n1653), SS104: glp-4(bn2), TJ356: <br />                                                 zIs356 (Ex(daf-16::gfp+rol-6)), TJ1060: spe-9(hc88); fer-15(b26), VC199: sir-2.1(ok434), <br />                                                 WM104: unc-101(sy216) gsk-3(nr2047)/hIn1(unc-54(h1040)) NL2099: rrf-3(pk1426) <br />                                                 obtained Caenorhabditis Genetic Center University Minnesota. Worms <br />                                                 cultured 6-cm nematode growth media (NGM) agar plates lawn live <br />                                                 Escherichia coli OP50 maintained 20 &#194;&#176;C unless stated. experiments                                                 performed hermaphrodite worms. <br />  <br />                               Lifespan Assay <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                 populations cultured 20 &#194;&#176;C 3 days reaching L4 larval stage,                                                 glp-4(bn2), cultured permissive temperature 16 &#194;&#176;C, shifted 25 <br />                                                 &#194;&#176;C eggs lifespan assay. Populations L4-stage worms transferred                                                 NGM plates LiCl (Sigma) specified subsequently maintained 25 &#194;&#176;C. <br />                                                 Populations examined 1&#226;&#8364;&#8220;2 days transferred new plates avoid starvation <br />                                                 larval crowding required. Death events noted failure respond touch                                                 platinum wire animals lost died internal larval hatching recorded                                                 censored data previously described (27). <br />  <br />  <br />  <br />  <br />                               4The abbreviations used  GSK-3&#206;&#178;, glycogen synthase kinase-3&#206;&#178;; IGF, insulin/insulin-like growth factor; FWER, family wise error <br />                               rate; HD, Huntington disease; NGM, nematode growth media; ICP, inductively coupled plasma optical emission spectroscopy; CR, <br />                               caloric restriction; GFP, green fluorescent protein; RNAi, RNA interference. <br />  <br />  <br />                                                     J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                           Page 3 <br />  <br />  <br />                               Fertility Assay <br />                                            synchronous wild-type hermaphrodites cultured 20 &#194;&#176;C 3 days reached <br />                                            L4 stage. 15 individual worms transferred maintained separate <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            NGM plate 10 mM LiCl cultured 25 &#194;&#176;C. Individuals transferred <br />                                            daily; progeny left develop 3 days counting. <br />  <br />                               Elemental Analysis <br />                                            Approximately 1 &#195;&#8212; 106 C. elegans eggs collected following hypochlorite treatment                                            hatched overnight S-basal synchronize development. cultures maintained 20 <br />                                            &#194;&#176;C. Larvae developed 3 days collected washed S-basal 15-ml <br />                                            polypropylene tubes (Corning). 50,000 adults transferred 10-cm NGM plates                                            10 mM LiCl, mixture incubated 24 h 25 &#194;&#176;C. plates ~ 1 ml <br />                                            2&#195;&#8212;1011 cells (OP50)/ml food source. Populations collected 10 ml S- <br />                                            basal filtered 40-&#194;&#181;m nylon cell strainers (BD Falcon) washed 200 ml                                            18 M&#206;&#169; milli-Q <span id='am-27' about='obo:IMR_0200357' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-28' property="rdfs:label" content="H2O" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasDbXref" content="KEGG:C00001" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:id" content="IMR:0200357" datatype="xsd:string"></span>H2O</span> (Millipore). Worms transferred 15-ml tubes pelleted brief <br />                                            centrifugation. Elemental analysis conducted using inductively coupled plasma <br />                                            optical emission spectroscopy (ICP) previously described (28). ICP routinely <br />                                            calibrated using National Institute Standards Technology (NIST)-traceable elemental <br />                                            standards (Sigma-Aldrich) validated using NIST-traceable test standards (sample 1577b, <br />                                            NIST); ICP reagents plastic ware company-certified routinely tested trace <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            metal work. Values shown averages replicates normalized weight growth <br />                                            media organism number worms. <br />  <br />                               Microarray Analysis <br />                                            Gene expression data collected using wild-type (N2 strain) nematodes comparing                                            untreated (control) populations common mixed stage reference RNA populations <br />                                            treated 10 mM LCl 48 h 25 &#194;&#176;C. populations initially cultured 20 &#194;&#176;C                                            3 days eggs reaching L4 stage transferred media                                            LiCl. biological replicate comprised total RNA extracted 50 <br />                                            nematodes using Absolute RNA Microprep Kit (Stratagene). Sample integrity                                            concentration determined using ND-1000 Spectrophotometer (NanodropTechnologies) <br />                                            Bioanalyzer Pico Chip (Agilent ). Total RNA samples amplified using <br />                                            Amino Allyl Message Amplification II Kit (Ambion ), using ~ 500 ng Total RNA. <br />                                            Sample integrity concentration determined using ND-1000 Spectrophotometer <br />                                            Bioanalyzer Pico Chip. AmplifiedRNAwas labeled using CyDye Post Labeling <br />                                            Reactive Dyes (Cy3 Cy5, GE Healthcare Bio-Sciences Corp.) conjunction                                            reagents protocol Amino Allyl Message Amplification II Kit. improve <br />                                            hybridization amplified RNA &#226;&#8364;&#339;fragmented&#226;&#8364;? using RNA Fragmentation kit (Ambion <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            ). Hybridization using Lucidea Slide Pro machine (GE Healthcare Bio-Sciences <br />                                            Corp.) using manufacturer&#226;&#8364;&#8482;s protocol. wash solutions (Nuclease-free Water, 20% SDS <br />                                            20&#195;&#8212; SSC) obtained Ambion  arrays obtained Washington <br />                                            University St. Louis Genomic Sequencing Center. Arrays scanned using Scan Array <br />                                            Express 2-Laser Scanner (PerkinElmer Life Sciences). Images quantitated using                                            GenePix 5.1 software package (Molecular Devices Corp.) using GAL file overlays provided <br />                                            Washington University St. Louis (Genomic Sequencing Center), GPR file                                            generated. gene annotations obtained Wormbase (release WS161). <br />  <br />                               Statistics <br />                                            Survival assays analyzed using non-parametric (Mantel-Haenszel) Log rank test                                            presented Kaplan-Meier survival curves (Prism&#226;&#8222;&#162; software package). Differences fertility <br />                                            elemental content determined using tailed Student&#226;&#8364;&#8482;s t test (Excel MS). <br />  <br />  <br />                                                 J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                                Page 4 <br />  <br />  <br />                                            differentially expressed genes microarray analysis, performed sample <br />                                            t-tests gene used FWER cut 5% marginal p values using                                            Holm&#226;&#8364;&#8482;s step method (29). Clusters similarly expressed genes using NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            hierarchical modification partitioning medoids algorithm, called HOPACH (30), <br />                                            orders data  case genes) display ordered distance matrix. <br />  <br />                                            Associations gene ontology   terms responding transcripts determined <br />                                            using mean difference log2 expression genes genes outside <br />                                             respectively. procedure performed GOs 25 constituent <br />                                            genes. Differentially expressed GOs identified using manner described <br />                                             using raw p values derived sample t test aFWERcut 5% based                                            slightly conservative Bonferroni correction multiple testing. <br />  <br />                               Mortality Analysis <br />                                            Estimates initial mortality rate rate increase age model fitting                                            using WinModest (31). Gompertz mortality curves, ln(ux) = ln  + bx, ux defines                                            age-specific hazard, fitted log-likelihood ratios used examined effects                                            constraining intercept   gradient (b) variables (31). <br />  <br />                               Cell Culture Immunochemical Analysis <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Human breast cancer cell line MCF7 obtained American Type Culture Collection <br />                                            (Manassas, VA). Cells cultured Dulbecco&#226;&#8364;&#8482;s modified Eagle&#226;&#8364;&#8482;s medium (Mediatech) <br />                                            10% fetal bovine serum (Mediatech), 1% penicillin/streptomycin (Mediatech), 10 &#194;&#181;g/ <br />                                            ml insulin (Sigma). 10-cm dishes, 1 &#195;&#8212; 106 cells plated normal media, attachment <br />                                            grown 24 h, treatment LiCl 48 72 h indicated prior fractionation <br />                                            extract preparation. Cells lysed 10 mM HEPES, pH 7.6, 10 mM KCl, 1.5 mM <br />                                            MgCl2, 0.3% IGEPAL, Complete, Mini, EDTA-free; Protease Inhibitor Mixture tablet <br />                                            (Roche) 10 ml lysis buffer, Dounce homogenizer. Nuclei pelleted                                            5000 rpm spin 5 min, lysed 100 &#194;&#181;l 100 mM NaCl, 25 mM Tris, pH 7.5,                                            2% SDS, 4 &#195;&#8212; 10 s pulses sonic disruption ice. Standard SDS-PAGE                                            immunodetection protocols used rabbit anti-LSD1 (Abcam) anti-Lamin C <br />                                            (Cell Signaling Technologies). <br />  <br />                               RESULTS <br />                               Lifespan C. elegans Exposed LiCl <br />                                            Cohorts pre-fertile wild-type worms exposed LiCl concentration range 5&#226;&#8364;&#8220; <br />                                            100 mM following development. Chronic LiCl treatment significantly increased median <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            maximum lifespan (Fig. 1, B). dose-response relationship observed                                            optimal lifespan increase seen 10 mM LiCl median wild-type lifespan increased <br />                                            46% (p &lt; 0.0001). degree variability extent lifespan extension                                            observed; replicates average median lifespan increase 36% (Table 1). <br />  <br />                                            determine lifespan extension associated increased intracellular Li+ <br />                                            concentrations, ICP used measure elemental content nematode populations.                                            control groups, Li+ detection limits (0.45 pmol worm), exposed <br />                                            10 mM LiCl 24 h average 6 pmol Li+ worm detected (supplemental <br />                                            Tables S1 S2). day-old wild-type worms approximate volume 5 nl (32); <br />                                            assuming homogenous distribution Li+ worm, estimate concentration <br />                                            Li+ ~ 1.2 mM. concentration falls therapeutic range serum <br />                                            concentration used treat bipolar disorder C. elegans treated 10 mM LiCl                                            provide physiologically appropriate model human treatment regimens (9). finding  <br />  <br />                                                J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                               Page 5 <br />  <br />  <br />                                             consistent view elevated intracellular Li+ responsible observed lifespan <br />                                             extension. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Fertility Effects LiCl <br />                                             Given wide variety potential targets Li+, toxicity expected high concentrations. <br />                                             Consistent  median worm lifespan significantly shortened 9%                                             exposed 100 mM LiCl (p &lt; 0.001; Fig. 1, B). addition, Li+ detrimental effect <br />                                             hermaphrodite self-fertility (Fig. 1C). Mean total progeny production 25 &#194;&#176;C unmated, <br />                                             untreated hermaphrodites 148.4 &#194;&#177; 7.1 (S.E.), 10 mM LiCl treated worms produced <br />                                             22.2 &#194;&#177; 2.2 (S.E.; p &lt; 0.0001). Li+-treated worms produced eggs, eggs                                             laid subsequently failed hatch. <br />  <br />                               Epistatic Interaction Known Li+ Target, GSK-3&#206;&#178; <br />                                             took pharmacogenetic approach understanding mechanism lifespan <br />                                             extension Li+. combine Li+ treatment effects specific single-gene <br />                                             mutations known targets Li+ genes known modulate aging rate. examined <br />                                             Li+ extends lifespan inhibition known target GSK-3&#206;&#178; using maternally <br />                                             rescued null gsk-3&#206;&#178;(nr2047) mutant. 36% reduction median lifespan gsk-3&#206;&#178;(nr2047) <br />                                             mutants observed compared wild type (p &lt; 0.0001, Table 1). Mutational loss                                             GSK-3&#206;&#178; appears detrimental lifespan. observation inconsistent model NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             Li+-induced lifespan extension exclusively inhibition GSK-3&#206;&#178; activity. Exposure <br />                                             gsk-3&#206;&#178;(nr2047) mutants Li+ causes  slight 7% decrease median lifespan <br />                                             (p &lt; 0.001).  inhibition GSK-3&#206;&#178; sufficient lifespan extension, <br />                                             lifespan extension Li+ actually requires GSK-3&#206;&#178;. <br />  <br />                               Epistatic Interaction Caloric Restriction <br />                                             Caloric restriction (CR) associated lifespan extension range species (33).                                             considered possibility Li+ induced caloric restriction causing aversion E. <br />                                             coli food source takes form circular lawn centered NGM plate. Li+                                             homogenously dispersed media caused observable alteration                                             distribution worms. Furthermore, C. elegans actually attracted Li+ agar plates <br />                                             (34).  examined possibility Li+ act CR mimetic reducing food <br />                                             intake acting signaling pathways downstream effectors CR. tested                                             hypothesis asking Li+ extend lifespan CR worms. EAT-2 nicotinic <br />                                             <span id='am-32' about='obo:IMR_0100111' typeof='owl:Thing obo:IMR_0001693 obo:IMR_0100121 obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0000001 obo:IMR_0002121'><span id='am-33' property="rdfs:label" content="O-Acetylcholine" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="acetylcholine" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasDbXref" content="KEGG:C01996" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:id" content="IMR:0100111" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasExactSynonym" content="O-Acetylcholine" datatype="xsd:string"></span>acetylcholine</span> receptor subunit required pharyngeal pumping (35). Worms mutations <br />                                             eat-2 exhibit slowed feeding rates extended lifespan (36) thought mimic <br />                                             CR. suggested mutation clk-1 gene extends lifespan mechanism <br />                                             similar CR. clk-1 mutant worms altered <span id='am-11' about='obo:IMR_0200483' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-12' property="oboInOwl:id" content="IMR:0200483" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="Ubiquinone" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasDbXref" content="KEGG:C00399" datatype="xsd:string"></span>ubiquinone</span> biosynthesis extend <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             lifespan mechanism related CR (37). observed Li+ treatment extends median <br />                                             lifespan eat-2 clk-1 mutants (33 35%, p &lt; 0.0001, respectively; Table 1).                                             number interpretations finding. possible single gene <br />                                             mutation produce maximum CR-associated lifespan extension, Li+ <br />                                             treatment increases CR action.  magnitude lifespan <br />                                             extension similar observed wild-type worms, data consistent                                             model CR Li+ treatment extend lifespan distinctive mechanisms. <br />  <br />                               Epistatic Interaction IGF/FOXO Signaling Pathway <br />                                             characterized influence C. elegans lifespan IGF/FOXO signaling <br />                                             pathway regulates activity FOXO-like transcription factor DAF-16. daf-2 <br />                                             gene encodes insulin-like receptor protein, hypomorphic mutations result                                             doubling lifespan (38). Li+ extended daf-2(e1368) median lifespan 19% (Table 1).  <br />  <br />                                                 J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                             Page 6 <br />  <br />  <br />                                            suggest independent mechanism, magnitude lifespan extension somewhat <br />                                            smaller observed wild-type worms. Lifespan extension daf-2(e1368) <br />                                            mutation requires integrity DAF-16; worms carrying mutations daf-2 NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            daf-16 exhibit normal lifespans. assess role IGF/FOXO signaling pathway <br />                                            Li+-induced lifespan extension, tested effect Li+ daf-16(mu86) worms,                                            lack functional DAF-16, observed 50% increase median lifespan (p &lt; 0.0001, Table <br />                                            1). strongly suggests Li+ does affect lifespan insulin signaling <br />                                            pathway. supported observations. Overexpression SIR-2,                                            NAD-dependent deacetylase, extends C. elegans lifespan (39), potentially interactions                                            DAF-16 (40). Li+ increases median lifespan sir-2.1 null mutants, consistent                                            observation Li+ affects longevity independently IGF/FOXO pathway. addition, <br />                                            treated worms expressing green fluorescent protein (GFP)-tagged DAF-16 (TJ356: <br />                                            zIs356 (Ex(daf-16::gfp+rol-6))). DAF-16::GFP protein located nucleus                                            daf-2 mutants stress (41). exposed worms expressing fusion protein <br />                                            10 mM LiCl, observed nuclear localization (Fig. 1D). conclude effect                                            Li+ lifespan reduced IGF/FOXO signaling. <br />  <br />                               Epistatic Interaction Germ Line Signaling <br />                                            Genetic laser ablation germ line precursor cells additional mechanism C. <br />                                            elegans extend lifespan (42). Worms carrying glp-4(bn2) allele sterile allowed <br />                                            develop 25 &#194;&#176;C essentially lacking germ line proliferation (43). lowered fertility NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Li+-treated worms prompted consider Li+ extend lifespan inhibiting germ <br />                                            line proliferation function.  Li+-treated glp-4(bn2) mutants                                            longer lived untreated mutants (22%, p &lt; 0.0001; Table 1). consistent <br />                                            Li+ affecting lifespan independently germ line effects lifespan. <br />  <br />                               Epistatic Interaction ced-9/bcl-2 <br />                                            considered Li+ acting mechanisms previously <br />                                            described possible targets mammalian systems. rats, Li+ treatment results                                            elevation bcl-2 levels brain regions (13,14). Similar increases reported <br />                                            Li+-treated human cells. rise bcl-2 levels explain lifespan effects Li+ <br />                                            clear neuroprotective role protein (15). C. elegans ortholog bcl-2 <br />                                            (CED-9) functions prevent cell death development (16,17). ask Li+ <br />                                            lifespan effects dependent CED-9 function, treated worms carrying ced-9 <br />                                            (n1653) loss function mutation (16) observed 78% increase median lifespan (p &lt; <br />                                            0.0001, Table 1). lack involvement CED-9 anti-apoptotic processes consistent                                            postmitotic status adult C. elegans preservation C. elegans nervous                                            C. elegans normal wild-type aging (44). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Genome-wide Transcript Response LiCl <br />                                            investigate biological action Li+ performed unbiased examination                                            mRNA abundance changes result exposure 10 mM LiCl, using genome <br />                                            microarray study. Differentially expressed genes identified t-tests comparing <br />                                            populations control versus Li+-treated worms. Using false discovery rate (45) &#226;&#8240;&#164; 0.01, <br />                                            observed 702 changes gene expression. imposed stringent FWER (29)                                            &#226;&#8240;&#164;0.05, reducing list 99 genes. identified 65 regulated 34 regulated <br />                                            transcripts, sorted geometric mean ratio shown supplemental <br />                                            Table S3. genes clustered using hierarchical clustering routine (HOPACH) <br />                                            possible coregulated suites genes (30). observed 9 distinct clusters, shown                                            ordered distance matrix (supplemental Fig. S1). Gene expression variation chips <br />                                            treatments plotted medoid values (supplemental Fig. S2).  <br />  <br />                                                J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                                  Page 7 <br />  <br />  <br />                                            performed analysis level identify common function responding genes.                                            identified significant GOs  FWER cut 0.05) associated Li+ treatment <br />                                            (supplemental Table S4), including nucleosome nucleosome assembly-associated genes <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            significantly represented response Li+ treatment. Validation subset                                            transcripts identified differentially expressed following Li+ treatment performed using <br />                                            quantitative reverser transcription-PCR (supplemental Table S5). <br />  <br />                               C. elegans LSD-1 Ortholog <br />                                            Following identification nucleosome nucleosome assembly-associated                                            decided closely examine potential nucleosome regulators list affected <br />                                            transcripts. observed transcripts T08D10.2, amine oxidase worm ortholog <br />                                            human LSD-1, reduced 0.33 controls following Li+ treatment (supplemental <br />                                            Table S3, . LSD-1 encodes histone demethylase (46). Treating RNAi-sensitive <br />                                            genetic background, rrf-3(pk1426) (47)  T08D10.2(RNAi) adulthood resulted                                            average median lifespan increase ~26% (p &lt; 0.001; Fig. 2A). Demographic analysis <br />                                            suggests rate increase age-specific mortality rate age significantly <br />                                            altered, increase shifted later age (p &lt; 0.01, Fig. 2B). effect consistent <br />                                            delay onset aging lowered intrinsic mortality, suggesting chromatin <br />                                            remodeling component aging C. elegans. <br />  <br />                               Effects LiCl Mammalian Cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Genetic effect aging appears conserved wide variety species,                                            probably result selection early life fitness traits development, fertility, stress <br />                                            resistance. raises possibility chemical compounds alter lifespan simple <br />                                            organisms affect aging mammals. LSD-1 important target Li+ C. <br />                                            elegans wish know mammalian LSD-1 regulated                                            mammalian cell line. determine conservation effects Li+ treated human breast <br />                                            cancer cell line MCF7 LiCl measured levels LSD-1 (Fig. 3, B).                                            LSD-1 responded chronic exposure Li+, approximate 50% reduction                                            72-h exposure 10 mM LiCl compared untreated controls. results consistent <br />                                            Li+ affecting LSD-1 mammalian cells tissues capable causing <br />                                            chromatin modification. <br />  <br />                               DISCUSSION <br />                                            study highlights utility C. elegans pharmacogenetic analysis drug activity <br />                                            raises possibility drug current use effects human aging <br />                                            phenotypes. especially true Li+ treated nematodes <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            measured using ICP falls close recommended therapeutic plasma levels (9). <br />  <br />                                            epistatic analysis Li+ mutations genes known alter aging C. <br />                                            elegans revealed genes required effect Li+ longevity, <br />                                            suggesting identified novel mechanism capable modulating aging. gene <br />                                            activity essential GSK-3&#206;&#178;. GSK-3&#206;&#178; inhibited Li+ directly competing                                            magnesium, required cofactor (48), indirectly increasing Ser-9 phosphorylation                                            unknown mechanism (49,50). Maternally rescued gsk-3&#206;&#178; null C. elegans decreased <br />                                            lifespan Li+-induced increase lifespan (Table 1). implies GSK-3&#206;&#178;                                            required Li+ action. result somewhat counterintuitive explained                                            reasons. Firstly, represent threshold effect, reduced adult GSK-3&#206;&#178;                                            different effects compared complete absence GSK-3&#206;&#178; activity. Secondly, <br />                                            inhibition GSK-3&#206;&#178; activity differing effects different tissues. C. elegans <br />                                            intestinal cells GSK-3&#206;&#178; inhibits SKN-1, transcription factor induces phase II <br />  <br />  <br />                                                J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                                    Page 8 <br />  <br />  <br />                                                detoxification genes, oxidative stress responses, required longevity (51). Inhibition <br />                                                GSK-3&#206;&#178; Li+ intestinal cells derepress SKN-1 potentially increase <br />                                                oxidative stress responses modulate aging.  reduced GSK-3&#206;&#178; activity NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                adult tissues detrimental; example, recently identified neuronal GSK-3&#206;&#178; <br />                                                potent pro-longevity factor.5 complete inhibition GSK-3&#206;&#178; activity tissues <br />                                                conflicting effects aging. <br />  <br />                                                Array analysis transcripts responding Li+ revealed changes, including ABC <br />                                                transporters regulation pgp-5 pgp-6, regulation ced-7 <br />                                                (supplemental Table S3). genes P-glycoprotein subclass <span id='am-16' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-17' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-23' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span>ATP</span>- <br />                                                binding cassette transporters, highly conserved dynamically evolving (52).                                                P-glycoproteins encoded pgp-5 -6 expressed intestinal cells (53)                                                predicted function efflux pumps protecting C. elegans exporting exogenous toxins. <br />                                                pgp-6 expressed adult amphid sensory neurons (53). Interestingly, P-glycoproteins <br />                                                component blood-brain barrier vertebrates, suggesting Li+ alter <br />                                                transport toxic compounds vertebrate brain effects conserved.                                                contrast, transcript ced-7 regulated (supplemental Table S3). Mutant alleles                                                ced-7 mutants defective engulfment cell corpses apoptosis (54). <br />  <br />                                                observed elevated levels mRNAs encoding histones (supplemental Table S3) <br />                                                response Li+.  identified replication-dependent histones  4, -7, -8, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                -45, -61, -62, -64, -67, -68), involved maintaining regular chromatin structure                                                replication nuclear DNA (55). remainder replacement histone  35) thought <br />                                                expressed constitutively tissue-specific manner. results consistent                                                Li+ causing changes nucleosome composition remodeling chromatin. results <br />                                                indicate Li+ causing attempt initiate DNA replication repair.                                                nematodes exposed Li+ late L4 larvae (3 days old) essentially somatic cells <br />                                                non-dividing (56), endoreduplication nuclear DNA observed limited <br />                                                number hypodermal cells (57).  analysis bromodeoxyuridine incorporation                                                identify cells undergoing DNA replication revealed differences untreated                                                Li+-treated worms (data shown). effect histone mRNAs originated                                                perturbation developing embryos utero, 10 mM LiCl clearly detrimental                                                early development (Fig. 1C). <br />  <br />                                                 propose Li+ chromatin effects particular adult tissues.                                                response Li+ transcript T08D10.2, worm ortholog Lsd-1, reduced 3-fold.                                                MCF7 human breast cancer cells Li+ reduced LSD-1 protein levels approximately  <br />                                                half untreated controls, suggesting effect Li+ broadly conserved. LSD-1 <br />                                                acts histone demethylase remodel chromatin (46). Chromatin composed dynamic <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                nucleosomes regulate DNA-dependent processes transcription, replication, <br />                                                recombination, repair (58). core histone proteins form nucleosomes                                                subject epigenetic code post-translational modifications (59). combination                                                modifications recruitment particular factors determine &#226;&#8364;&#339;openness&#226;&#8364;?                                                chromatin domains ability region DNA function. regulation gene <br />                                                silencing chromatin modification proposed determinant organismal aging (60). <br />  <br />                                                process normal aging intrinsically linked late onset neurodegenerative diseases. <br />                                                 cellular 5 G. McColl G. J. Lithgow, unpublished data. changes events <br />                                                aging impact neurodegeneration understood. screen candidate <br />                                                therapeutic compounds C. elegans HD model, Li+ shown suppress HD neurotoxicity <br />                                                (26). Consistent longevity experiments FOXO-like transcription factor DAF-16 <br />  <br />  <br />                               5G. McColl G. J. Lithgow, unpublished data. <br />  <br />  <br />                                                     J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                                              Page 9 <br />  <br />  <br />                                            required neuroprotective effect. results suggest shared <br />                                            mechanism protection polyglutamine disease extended lifespan. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            Studies using HD models shown mutant huntingtin expression leads change <br />                                            histone acetyl transferase activity. aberrant acetyltransferase activity resulting <br />                                            chromatin remodeling lead transcriptional dysregulation  ultimately, neuronal <br />                                            dysfunction HD (61). Furthermore, therapeutic role histone deacetylase inhibitors                                            number HD models recently reported. contrast, overexpression C. elegans <br />                                            SIR-2.1, deacetylases, extends longevity (39).  direct interaction histones <br />                                            SIR-2.1 remains shown. results suggest regulation chromatin <br />                                            remodeling affect neuroprotection polyglutamine disease modulate organismal <br />                                            aging. <br />  <br />                                            summary, identified novel indirect target Li+, LSD-1, effects                                            longevity. molecular details Li+ alters survival modulating histone methylation <br />                                            chromatin structure require study.  C. elegans useful model                                            dissect mechanisms. use simple model organisms developed genetics <br />                                            tools expedite identification molecular targets signaling pathways affected drug <br />                                            administration facilitate development improved therapies disease states                                            disorders. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Supplementary Material <br />                                            Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                            thank Gary K. Scott, Krysta Felkey, Lawreen Asuncion, Amanda Foster, Michael Benedetti technical <br />                                            assistance, Nicole Jenkins, Silvestre Alavez, Aiden Leigh, members Lithgow laboratory helpful <br />                                            discussions. thank Y. Bei C. Mello generous gift WM21 strain. <br />  <br />  <br />                               REFERENCES <br />                                            1. Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, Wallace DC, Malfroy B, Doctrow <br />                                               SR, Lithgow GJ. Science 2000;289:1567&#226;&#8364;&#8220;1569. [PubMed: 10968795] <br />                                            2. Keaney M, Gems D. Free Radic. Biol. Med 2003;34:277&#226;&#8364;&#8220;282. [PubMed: 12521609] <br />                                            3. Sampayo JN, Olsen  Lithgow GJ. Aging Cell 2003;2:319&#226;&#8364;&#8220;326. [PubMed: 14677634] <br />                                            4. Evason K, Huang C, Yamben  Covey DF, Kornfeld K. Science 2005;307:258&#226;&#8364;&#8220;262. [PubMed: <br />                                               15653505] <br />                                            5. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin  Chung P, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               Kisielewski  Zhang LL, Scherer B, Sinclair DA. Nature 2003;425:191&#226;&#8364;&#8220;196. [PubMed: 12939617] <br />                                            6. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. Nature 2004;430:686&#226;&#8364;&#8220;689. <br />                                               [PubMed: 15254550] <br />                                            7. Klein PS, Melton DA. Proc. Natl. Acad. Sci. U. S. 1996;93:8455&#226;&#8364;&#8220;8459. [PubMed: 8710892] <br />                                            8. Cade JFJ. Med. J. Aust 1949;2:349&#226;&#8364;&#8220;352. [PubMed: 18142718] <br />                                            9. Price LH, Heninger GR. N. Engl. J. Med 1994;331:591&#226;&#8364;&#8220;598. [PubMed: 8047085] <br />                                            10. Phiel CJ, Klein PS. Annu. Rev. Pharmacol. Toxicol 2001;41:789&#226;&#8364;&#8220;813. [PubMed: 11264477] <br />                                            11. Masuda CA, Xavier MA, Mattos KA, Galina  Montero-Lomeli M. J. Biol. Chem 2001;276:37794&#226;&#8364;&#8220; <br />                                                 37801. [PubMed: 11500487] <br />                                            12. Inoue K, Zhuang L, Maddox DM, Smith SB, Ganapathy V. Biochem. J 2003;374:21&#226;&#8364;&#8220;26. [PubMed: <br />                                                 12826022] <br />                                            13. Chen RW, Chuang DM. J. Biol. Chem 1999;274:6039&#226;&#8364;&#8220;6042. [PubMed: 10037682] <br />  <br />  <br />  <br />  <br />                                                J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                               Page 10 <br />  <br />  <br />                                            14. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK. J. Neurochem 1999;72:879&#226;&#8364;&#8220; <br />                                                882. [PubMed: 9930766] <br />                                            15. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Nature 1990;348:334&#226;&#8364;&#8220;336. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                [PubMed: 2250705] <br />                                            16. Hengartner MO, Ellis  Horvitz HR. Nature 1992;356:494&#226;&#8364;&#8220;499. [PubMed: 1560823] <br />                                            17. Hengartner MO, Horvitz HR. Cell 1994;76:665&#226;&#8364;&#8220;676. [PubMed: 7907274] <br />                                            18. Mudher  Shepherd D, Newman TA, Mildren P, Jukes JP, Squire  Mears  Drummond JA, Berg <br />                                                S, MacKay D, Asuni AA, Bhat R, Lovestone S. Mol. Psychiatry 2004;9:522&#226;&#8364;&#8220;530. [PubMed: <br />                                                14993907] <br />                                            19. Perez M, Hernandez F, Lim F, az-Nido J, Avila J. J. Alzheimers Dis 2003;5:301&#226;&#8364;&#8220;308. [PubMed: <br />                                                14624025] <br />                                            20. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, <br />                                                Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K. Proc. Natl. <br />                                                Acad. Sci. U. S. 2005;102:6990&#226;&#8364;&#8220;6995. [PubMed: 15867159] <br />                                            21. Phiel CJ, Wilson CA, Lee VM, Klein PS. Nature 2003;423:435&#226;&#8364;&#8220;439. [PubMed: 12761548] <br />                                            22. Nonaka S, Katsube N, Chuang DM. J. Pharmacol. Exp. Ther 1998;286:539&#226;&#8364;&#8220;547. [PubMed: 9655900] <br />                                            23. Carmichael J, Sugars KL, Bao YP, Rubinsztein DC. J. Biol. Chem 2002;277:33791&#226;&#8364;&#8220;33798. [PubMed: <br />                                                12097329] <br />                                            24. Berger  Ttofi EK, Michel CH, Pasco  Tenant S, Rubinsztein DC, O&#226;&#8364;&#8482;Kane CJ. Hum. Mol. Genet <br />                                                2005;14:3003&#226;&#8364;&#8220;3011. [PubMed: 16141285] <br />                                            25. Watase K, Gatchel JR, Sun Y, Emamian E, Atkinson R, Richman R, Mizusawa H, Orr HT, Shaw C, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                Zoghbi HY. PLoS Med 2007;4:e182. [PubMed: 17535104] <br />                                            26. Voisine C, Varma H, Walker N, Bates EA, Stockwell BR, Hart AC. PLoS 2007;2:e504. <br />                                                [PubMed: 17551584] <br />                                            27. McColl G, Vantipalli MC, Lithgow GJ. FASEB J 2005;19:1716&#226;&#8364;&#8220;1718. [PubMed: 16099946] <br />                                            28. Killilea DW, Atamna H, Liao C, Ames BN. Antioxid. Redox. Signal 2003;5:507&#226;&#8364;&#8220;516. [PubMed: <br />                                                14580305] <br />                                            29. Holm S. Scand. J. Stat 1979;6:65&#226;&#8364;&#8220;70. <br />                                            30. van der Laan MJ, Pollard KS. J. Stat. Plan. Inf 2003;117:275&#226;&#8364;&#8220;303. <br />                                            31. Pletcher SD. J. Evol. Biol 1999;12:430&#226;&#8364;&#8220;439. <br />                                            32. Hirose T, Nakano Y, Nagamatsu Y, Misumi T, Ohta H, Ohshima Y. Development 2003;130:1089&#226;&#8364;&#8220; <br />                                                1099. [PubMed: 12571101] <br />                                            33. Bordone L, Guarente L. Nat. Rev. Mol. Cell. Biol 2005;6:298&#226;&#8364;&#8220;305. [PubMed: 15768047] <br />                                            34. Ward S. Proc. Natl. Acad. Sci. U. S. 1973;70:817&#226;&#8364;&#8220;821. [PubMed: 4351805] <br />                                            35. McKay JP, Raizen DM, Gottschalk  Schafer WR, Avery L. Genetics 2004;166:161&#226;&#8364;&#8220;169. [PubMed: <br />                                                15020415] <br />                                            36. Lakowski B, Hekimi S. Proc. Natl. Acad. Sci. U. S. 1998;95:13091&#226;&#8364;&#8220;13096. [PubMed: 9789046] <br />                                            37. Wong  Boutis P, Hekimi S. Genetics 1995;139:1247&#226;&#8364;&#8220;1259. [PubMed: 7768437] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            38. Kenyon C. Cell 2005;120:449&#226;&#8364;&#8220;460. [PubMed: 15734678] <br />                                            39. Tissenbaum HA, Guarente L. Nature 2001;410:227&#226;&#8364;&#8220;230. [PubMed: 11242085] <br />                                            40. Berdichevsky  Viswanathan M, Horvitz HR, Guarente L. Cell 2006;125:1165&#226;&#8364;&#8220;1177. [PubMed: <br />                                                16777605] <br />                                            41. Henderson ST, Johnson TE. Curr. Biol 2001;11:1975&#226;&#8364;&#8220;1980. [PubMed: 11747825] <br />                                            42. Hsin H, Kenyon C. Nature 1999;399:362&#226;&#8364;&#8220;366. [PubMed: 10360574] <br />                                            43. Beanan MJ, Strome S. Development 1992;116:755&#226;&#8364;&#8220;766. [PubMed: 1289064] <br />                                            44. Herndon LA, Schmeissner PJ, Dudaronek JM, Brown PA, Listner KM, Sakano Y, Paupard MC, Hall <br />                                                DH, Driscoll M. Nature 2002;419:808&#226;&#8364;&#8220;814. [PubMed: 12397350] <br />                                            45. Benjamini Y, Hochberg Y. J. Roy. Stat. Soc. Ser. B 1995;57:289&#226;&#8364;&#8220;300. <br />                                            46. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y. Cell 2004;119:941&#226;&#8364;&#8220; <br />                                                953. [PubMed: 15620353] <br />  <br />  <br />  <br />  <br />                                                J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                                Page 11 <br />  <br />  <br />                                            47. Sijen T, Fleenor J, Simmer F, Thijssen KL, Parrish S, Timmons L, Plasterk RH,  Cell <br />                                                2001;107:465&#226;&#8364;&#8220;476. [PubMed: 11719187] <br />                                            48. Ryves WJ, Harwood AJ. Biochem. Biophys. Res. Commun 2001;280:720&#226;&#8364;&#8220;725. [PubMed: 11162580] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            49. Sarno P, Li X, Jope RS. Neuropharmacology 2002;43:1158&#226;&#8364;&#8220;1164. [PubMed: 12504922] <br />                                            50. Jope RS. Trends Pharmacol. Sci 2003;24:441&#226;&#8364;&#8220;443. [PubMed: 12967765] <br />                                            51. JH, Vranas K, Lucke M, Inoue H, Hisamoto N, Matsumoto K, Blackwell TK. Proc. Natl. Acad. <br />                                                Sci. U. S. 2005;102:16275&#226;&#8364;&#8220;16280. [PubMed: 16251270] <br />                                            52. Sheps JA, Ralph S, Zhao  Baillie DL, Ling V. Genome Biol 2004;5:R15. [PubMed: 15003118] <br />                                            53. Zhao  Sheps JA, Ling V, Fang LL, Baillie DL. J. Mol. Biol 2004;344:409&#226;&#8364;&#8220;417. [PubMed: 15522294] <br />                                            54. Wu YC, Horvitz HR. Cell 1998;93:951&#226;&#8364;&#8220;960. [PubMed: 9635425] <br />                                            55. Pettitt J, Crombie C, Schumperli D, Muller B. J. Cell Sci 2002;115:857&#226;&#8364;&#8220;866. [PubMed: 11865041] <br />                                            56. Sulston JE, Horvitz HR. Dev. Biol 1977;56:110&#226;&#8364;&#8220;156. [PubMed: 838129] <br />                                            57. Flemming AJ, Shen ZZ, Cunha  Emmons SW, Leroi  Proc. Natl. Acad. Sci. U. S.                                                2000;97:5285&#226;&#8364;&#8220;5290. [PubMed: 10805788] <br />                                            58. Mellor J. Trends Genet 2006;22:320&#226;&#8364;&#8220;329. [PubMed: 16631276] <br />                                            59. Peterson CL, Laniel MA. Curr. Biol 2004;14:R546&#226;&#8364;&#8220;R551. [PubMed: 15268870] <br />                                            60. Guarente L, Kenyon C. Nature 2000;408:255&#226;&#8364;&#8220;262. [PubMed: 11089983] <br />                                            61. Sadri-Vakili G, Cha JH. Nat. Clin. Pract. Neurol 2006;2:330&#226;&#8364;&#8220;338. [PubMed: 16932577] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                            Page 12 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            FIGURE 1. Effects LiCl wild-type C. elegans lifespan fertility <br />                                             Kaplan-Meier survival curves hermaphrodite worm populations exposed 0&#226;&#8364;&#8220;100 mM <br />                                            LiCl. B, fraction gain median survival (days) wild-type populations cultured 0&#226;&#8364;&#8220;100 <br />                                            mM LiCl. C, effects 10 mM LiCl wild-type C. elegans fertility 25 &#194;&#176;C. data presented <br />                                            mean &#194;&#177; S.E. **, p &lt; 0 01; ***, p &lt; 0.001. D, 24-h exposure 10 mM LiCl effect <br />                                            DAF-16 nuclear localization. Fluorescence micrographs DAF-16::GFP expression 4- <br />                                            dayold animals. Untreated control animal   individuals given 24-h exposure 10 mM <br />                                            LiCl (ii) 2h 33 &#194;&#176;C heat shock (iii). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                               Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            FIGURE 2. Effects T08D10.2(RNAi) C. elegans lifespan <br />                                             Kaplan-Meier survival curve showing median lifespan 15 days (control) versus 19 days <br />                                            T08D10.2(RNAi), p &lt; 0.001. B, log-linear plot mortality rate versus age shown                                            control T08D10.2(RNAi)-treated C. elegans. Gompertz curves fitted,                                            mortality rate increase different;  significant difference initial <br />                                            mortality rate (p &lt; 0.01) consistent shift mortality curve later ages following <br />                                            T08D10.2(RNAi). <br />  <br />  <br />  <br />  <br />                                                J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                             McColl et al.                                                                                        Page 14 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            FIGURE 3. LiCl reduces Lsd-1 levels MCF7 cells <br />                                            Immunoblot showing reduced LSD-1 levels following 48-h  72-h (B) exposure                                            LiCl concentrations shown. LSD-1 levels shown relative untreated controls following                                            correction loading differences using Lamin C levels. <br />  <br />  <br />  <br />  <br />                                               J Biol Chem. Author manuscript; available PMC 2009 September 8. <br />                                                                       NIH-PA Author Manuscript                              NIH-PA Author Manuscript                               NIH-PA Author Manuscript <br />                                                                                                                                              TABLE 1 <br />                                                                                           Lifespan effects 25 &#194;&#176;C post-developmental exposure 10mM LiCl <br />                                                                                           Median life-span (LS) days 25 &#194;&#176;C populations treated (+) (&#226;&#710;&#8217;) 10 mM LiCl. Genotype drug compared <br />                                                                                           line 1, percentage change median LS genotype (gt) shown compared statistical difference. Percentage <br />                                                                                           changes median LS Li+ based comparisons genotype drug treatment. n number                                                                                           hermaphrodites examined, number censored animals shown parentheses. &#226;&#8364;&#339;Replicates&#226;&#8364;? indicates number independent <br />                                                                                           experiments. <br />                                                                                                                                                                                                                                  McColl et al. <br />  <br />  <br />  <br />  <br />                                                                         Genotype                          LiCl                Median               Median              Median                  n                 Replicates <br />                                                                                                                                LS                  increase            increase <br />                                                                                                                                                      (gt)                (Li+) <br />  <br />  <br />                                                                                                                                                                % <br />                                                                         Wild type                          &#226;&#710;&#8217;                   10.6                                                         922 (94)                 11 <br />                                                                                                            +                   14.5a                                    +36%                1141 (29) <br />  <br />                                                                         gsk-3&#206;&#178;(nr2047)b                    &#226;&#710;&#8217;                   7.0a                 &#226;&#710;&#8217;36%                                     156 (9)                 2 <br />  <br />                                                                                                            +                   6.5c                                     &#226;&#710;&#8217;7%                 147 (13) <br />  <br />                                                                         eat-2(ad465)                       &#226;&#710;&#8217;                   12.0                 +9%                                      94 (13)                 2 <br />                                                                                                            +                   16.0a                                    +33%                206 (21) <br />  <br />                                                                         clk-1(e2519)                       &#226;&#710;&#8217;                   13.0                 +18%                                    166 (22)                 2 <br />                                                                                                            +                   17.5a                                    +35%                 190 (7) <br />  <br />                                                                         daf-2(e1368)                       &#226;&#710;&#8217;                   14.0                 +27%                                    143 (19)                 2 <br />                                                                                                            +                   17.0a                                    +21%                146 (11) <br />  <br />                                                                         daf-16(mu86)                       &#226;&#710;&#8217;   <br /> </body></html>